BioSpace News Archive

Drug Development

OPKO Health Enrolls First Patient in Phase IIB Study of OPK88004 to Treat Benign Prostatic Hypertrophy

Enlarged prostate affects approximately 50 million men in the U.S.

November 27, 2017
·
6 min read
Policy

Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System

The DenerveX System is CE Marked in Europe and it is commercially available in Europe and certain other international markets.

November 27, 2017
·
3 min read
Genetown

CSA Medical Announces Enrollment of First Patient Into a Dedicated Esophageal Cancer Trial Using truFreeze Rapid AV

CSA Medical is pleased to announce the enrollment of the first patient into a multi-center prospective study evaluating the effects of spray cryotherapy on patients suffering from esophageal cancer.

November 27, 2017
·
2 min read
Drug Development

TG Therapeutics Announces Initiation of National Cancer Institute/SWOG-Sponsored Randomized Phase II Trial in Follicular Lymphoma

TGR-1202 (umbralisib) selected as the PI3K Delta inhibitor to be used in this multiple arm comparison study

November 27, 2017
·
5 min read
Business

Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development

Dr. Weyer most recently served as President and Chief Development Officer of ProSciento,

November 27, 2017
·
5 min read
BASF to Increase Prices for Formic Acid and Propionic Acid in the EMEA Region

Prices for all other concentrations of Formic Acid will be increased accordingly on a pro rata basis.

November 27, 2017
·
1 min read
Storm Therapeutics Announces Publication in Nature on RNA Epigenetics by Founder Professor Tony Kouzarides

The study has found an unexpected new drug target for acute myeloid leukaemia that could open new avenues to develop effective treatments against this potentially lethal disease.

November 27, 2017
·
2 min read
JPMorgan Chase & Co Notifies 3.12% Shareholding in TiGenix

TiGenix publishes today a transparency notification pursuant to Article 14 of the Belgian Law of May 2, 2007 regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated market and including various provisions.

November 27, 2017
·
2 min read
Medical Artificial Intelligence Company Quantib Receives Capital Injection of EUR 4.5 Million

The presentation of Prof. Hartmut Ehrlich, M.D., CEO of ABIVAX is scheduled for Tuesday, November 28th, 11:30am CET in Room Oslo.

November 27, 2017
·
2 min read
Guerbet Reinforces its Expertise With the Launch of Contrast&Care, a Contrast Media Injection Management Solution for Radiology Centers

The launch of the solution is part of the strategy of Guerbet to develop a portfolio of digital solutions to optimize the care and management of patients by healthcare professionals.

November 27, 2017
·
3 min read